Copyright
©The Author(s) 2017.
World J Gastrointest Endosc. Feb 16, 2017; 9(2): 77-84
Published online Feb 16, 2017. doi: 10.4253/wjge.v9.i2.77
Published online Feb 16, 2017. doi: 10.4253/wjge.v9.i2.77
Table 1 Patients’ background and disease background
VisiGlide2TM | VisiGlideTM | P value | ||
Sex | 122 males | 113 males | NS | |
80 females | 81 females | |||
Age | 72.871 ± 11.403 (36-98) | 70.834 ± 11.824 (38-95) | NS | |
Disease | Bile duct stone | 113 | 103 | NS |
Cholangiocarcinoma | 31 | 26 | NS | |
Chronic pancreatitis | 14 | 18 | NS | |
Pancreatic cancer | 18 | 16 | NS | |
Gallbladder cancer | 3 | 6 | NS | |
Hepatolithiasis | 1 | 5 | NS | |
Metastatic biliary obstruction | 5 | 5 | NS | |
IPMN | 3 | 4 | NS | |
Benign biliary stenosis | 4 | 3 | NS | |
Acute cholecystitis | 5 | 3 | NS | |
PSC | 2 | 2 | NS | |
Postoperative bile leakage | 1 | 1 | NS | |
Pancreaticobiliary maljunction | 1 | 1 | NS | |
Duodenal papillary cancer | 1 | 1 | NS | |
Target region | Bile duct | 190 | 180 | NS |
Pancreatic duct | 12 | 14 | NS | |
Stenosed lesion | Present | 90 | 77 | NS |
Absent | 112 | 117 | NS | |
Procedure | Scheduled ERCP | 157 | 155 | NS |
Emergency | 45 | 39 | NS | |
Purpose | Diagnosis | 10 | 14 | NS |
Diagnosis + treatment | 15 | 9 | NS | |
Treatment | 177 | 171 | NS | |
Papillary treatment | None | 80 | 81 | NS |
Post EST | 110 | 101 | NS | |
Post EPST | 12 | 12 | NS |
- Citation: Sakai Y, Tsuyuguchi T, Hirata N, Nakaji S, Shimura K, Nishikawa T, Fujimoto T, Hamano T, Nishino T, Yokosuka O. Clinical utility of 0.025-inch guidewire VisiGlide2TM in the endoscopic retrograde cholangiopancreatography-related procedures. World J Gastrointest Endosc 2017; 9(2): 77-84
- URL: https://www.wjgnet.com/1948-5190/full/v9/i2/77.htm
- DOI: https://dx.doi.org/10.4253/wjge.v9.i2.77